Home» Country Reports» Country Wise Reports» USA Back
 

S.No. Date Title Subject Country
1 09 Jun 2017 Micro Therapeutic Research Labs Pvt. Ltd (MTR) has Successfully Cleared USFDA Inspection USFDA USA
2 21 Sep 2016 CDER SBIA Webinar - Establishment Registration and Listing for Human Drugs Information USA
3 01 Apr 2016 Labeling for Biosimilar Products - Guidance for Industry Guidelines USA
4 25 Mar 2016 FDA Perspective on Continuous Manufacturing USFDA USA
5 25 Mar 2016 FDA calls on manufacturers to begin switch from batch to continuous production News USA
6 25 Mar 2016 Continuous Manufacturing of Liposomal Drug Formulations USFDA USA
7 03 Nov 2015 Regulations Govt Notice Document Information USA
8 20 Jun 2015 Monthly Commercial Report for May, 2015 - EoI WASHINGTON, DC Reports USA
9 19 May 2015 Patents and Exclusivity USFDA USA
10 22 Apr 2015 Generic Drug User Fees; Public Meeting Information USA
11 20 Apr 2015 A Report of Pharmexcil -US FDA Interactive Meeting 18.03.2015 Report USA
12 26 Mar 2015 US FDA issues new bioavailability guidelines USFDA USA
13 31 Dec 2014 Guidance for Industry Bioequivalence Recommendations for Specific Products USFDA USA
14 24 Dec 2014 TBT notification issued by United States of America on Drugs TBT Notification USA
15 20 Nov 2014 FDA Requesting Comment on Proposed Criteria for “First Generic” Submission​s USFDA USA
16 03 Nov 2014 ANDA Submissions ― Refuse-to-Receive Standards Guidance for Industry USFDA USA
17 03 Nov 2014 Determinat​ion That TOPICORT (Desoximet​asone) Cream and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiven​ess USFDA USA
18 23 Oct 2014 FDA Finalizes Policy to Cut Down on Suspicious Behavior During Facility Inspection​s USFDA USA
19 06 Jul 2014 US FDA issues draft strategic priorities document USFDA USA
20 03 Jun 2014 Rule Change on Generic Drug Labeling Could Cost Billions USFDA USA